No Data
No Data
No Data
No Data
No Data
Analysts Offer Insights on Healthcare Companies: Icecure Medical (ICCM), Viracta Therapeutics (VIRX) and Bioxcel Therapeutics (BTAI)
TipRanksApr 16 06:30 ET
IceCure Medical Announces Upcoming Shareholders Meeting
TipRanksApr 15 21:02 ET
IceCure Medical Eyes FDA Approval With Promising Trial Results
TipRanksApr 15 20:58 ET
IceCure Medical Seeks FDA Nod For ProSense to Treat Early-Stage Breast Cancer
IceCure Medical (ICCM) said it has submitted final data to the US Food and Drug Administration seeking marketing authorization for ProSense to treat early-stage T1 invasive breast cancer patients with
MT NewswiresApr 15 15:01 ET
Express News | Icecure Medical Reports Final Ice3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing Authorization to Treat Early-Stage Breast Cancer
Moomoo 24/7Apr 15 08:35 ET
IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing Authorization to Treat Early-Stage Breast Cancer
Data presentation at highly influential American Society of Breast Surgeons ("ASBrS") Annual Meeting by Dr. Richard Fine wins Scientific Impact Award as voted by breast surgeons.
PR NewswireApr 15 08:35 ET
No Data
No Data